Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 133 500 KRW -1.33% Market Closed
Market Cap: 1.5T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Relative Value

The Relative Value of one Daewoong Pharma stock under the Base Case scenario is 207 701.38 KRW. Compared to the current market price of 133 500 KRW, Daewoong Pharma is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
207 701.38 KRW
Undervaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
42
vs Industry
70
Median 3Y
1.2
Median 5Y
1.2
Industry
2.6
Forward
1.1
vs History
61
vs Industry
34
Median 3Y
25.7
Median 5Y
25.7
Industry
23
Forward
23
vs History
31
vs Industry
34
Median 3Y
17.6
Median 5Y
18.8
Industry
17.8
vs History
47
vs Industry
6
Median 3Y
42.1
Median 5Y
31.7
Industry
25.4
vs History
50
vs Industry
43
Median 3Y
2.3
Median 5Y
2.4
Industry
2.2
vs History
44
vs Industry
70
Median 3Y
1.3
Median 5Y
1.3
Industry
2.8
Forward
1.2
vs History
57
vs Industry
70
Median 3Y
2.6
Median 5Y
3
Industry
5.4
vs History
66
vs Industry
37
Median 3Y
10.7
Median 5Y
14.7
Industry
13.7
Forward
8.3
vs History
69
vs Industry
35
Median 3Y
14.8
Median 5Y
20.9
Industry
17.2
Forward
10.9
vs History
34
vs Industry
34
Median 3Y
18.7
Median 5Y
21
Industry
16.5
vs History
vs Industry
10
Median 3Y
35.6
Median 5Y
34.3
Industry
19.3
vs History
55
vs Industry
59
Median 3Y
1.2
Median 5Y
1.3
Industry
2

Multiples Across Competitors

Competitors Multiples
Daewoong Pharma Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Daewoong Pharma
KRX:069620
1.5T KRW 1.1 16.9 9.3 12.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
KR
Daewoong Pharma
KRX:069620
Average P/E: 31.3
16.9
9%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top